Al-Ola Abdallah
Hematology — University of Kansas Medical Center, United States
Al-Ola Abdallah
LeadR Profile
Hematology
Subspecialties: Oncology - Transplantation - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 300
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Masked divergence in cancer mortality following COVID-19 disruption. mortality, neoplasms, covid-19, diagnosis, pandemics, therapeutics | Cancer Epidemiol | 2026 | 0 |
| Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC. cells, neoplasms, multiple myeloma, therapeutics, antibodies, bispecific | Curr Oncol | 2026 | 0 |
| From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma. quality of life, multiple myeloma, therapeutics, hematologic diseases, digital health | Expert Rev Hematol | 2026 | 0 |
| Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients. neoplasms, chromosome aberrations, transplants, therapeutics, cytogenetics | Curr Oncol | 2026 | 0 |
| High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis. proteasome inhibitors, microscopy, electron, scanning transmission, neoplasms, multiple chronic conditions, maintenance, aged, multiple myeloma, therapeutics, cytogenetics | Curr Oncol | 2026 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma NCT05827016 — cells, microscopy, electron, scanning transmission, multiple chronic conditions, stem cells, maintenance, multiple myeloma, lenalidomide, transplants, therapeutics, cell transplantation, stem cell transplantation, transplantation | Phase 3 | Active not recruiting | 2023 |
| A Study to Evaluate Mezigdomide Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) NCT05519085 — dexamethasone, bortezomib, multiple myeloma, calcium, calcium dobesilate | Phase 3 | Recruiting | 2022 |
LeadR Networks
Main global connection map